Furthermore, inactivating mutations of PROK2 and PROKR2 have been discovered in 2–7% of patients with Kallmann syndrome, who suffer from anosmia and hypogonadotropic hypogonadism [33]. This evidence concerns the gene PROK2 and Kallmann syndrome.